PARA_OA_008 top-line data readout September 2022
• Canine OA model preliminary data readout Q3 CY2022
• PARA_OA_002 Update – First data safety monitoring board review Q4 CY2022
• PARA_OA_006 extension study commencement Q4 CY2022
• FY22 tax rebate Q4 CY2022
• Further IP generation and protection
• MPS-I data presented at International Conference on Lysosomal Diseases Q1 CY2023
• PARA_OA_008 6-month data Q1 CY2023
• Canine OA Model – 20-week follow-up (3-year human equivalent) data
Q1 CY2023
• PARA_OA_002 Stage 1 dose selection 1H CY2023.
• Paradigm is currently in active discussion with multiple potential partners for its Phase 2 asset in Mucopolysaccharidosis (MPS).
- Forums
- ASX - By Stock
- PAR
- Ann: Paradigm Launches $66M Capital Raising
Ann: Paradigm Launches $66M Capital Raising, page-13
- There are more pages in this discussion • 120 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.0¢ |
Change
0.025(9.80%) |
Mkt cap ! $96.19M |
Open | High | Low | Value | Volume |
26.5¢ | 28.5¢ | 26.5¢ | $211.7K | 762.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 76718 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.0¢ | 13541 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 76718 | 0.275 |
3 | 15359 | 0.270 |
2 | 34459 | 0.265 |
6 | 94496 | 0.260 |
3 | 214982 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.280 | 13541 | 3 |
0.285 | 38667 | 2 |
0.290 | 28830 | 5 |
0.295 | 18068 | 2 |
0.300 | 25136 | 4 |
Last trade - 13.06pm 30/04/2024 (20 minute delay) ? |
|
|||||
Last
28.0¢ |
  |
Change
0.025 ( 7.69 %) |
|||
Open | High | Low | Volume | ||
26.5¢ | 28.5¢ | 26.5¢ | 206051 | ||
Last updated 13.12pm 30/04/2024 ? |
Featured News
PAR (ASX) Chart |